CRL
What one share of Charles River Laboratories International holds
Services – Commercial Physical and Biological Research
The SEC maintains an Internet site (http://www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.
Charles River Laboratories International’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-27; the balance sheet is as of 2026-06-27.
| Sales | $82.01 |
|---|---|
| Profit | −$4.89 |
| Capex (buildings and equipment) | $4.34 |
| Free cash flow | $7.60 |
| Cash and investments | $4.02 |
| Debt | $55.03 |
| Book value | $59.50 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $35.06 | $3.23 | $1.15 | $5.46 | — | $17.67 |
| 2017 | $38.25 | $2.54 | $1.70 | $4.85 | — | $22.05 |
| 2018 | $46.23 | $4.62 | $2.86 | $6.14 | — | $27.33 |
| 2019 | $52.75 | $5.07 | $2.83 | $6.85 | — | $33.40 |
| 2020 | $57.77 | $7.20 | $3.29 | $7.51 | — | $42.49 |
| 2021 | $68.84 | $7.60 | $4.45 | $10.35 | — | $50.21 |
| 2022 | $77.50 | $9.48 | $6.33 | $5.75 | — | $58.42 |
| 2023 | $80.26 | $9.22 | $6.19 | $7.10 | — | $70.06 |
| 2024 | $78.45 | $0.20 | $4.51 | $9.72 | — | $67.69 |
| 2025 | $81.01 | −$2.91 | $4.42 | $10.46 | — | $64.30 |